title: Do ITPA and TPMT genotypes predict the development of side effects to AZA?
authors.forename: J A
authors.initials: JA
authors.lastname: Duley
authors.forename: A M
authors.initials: AM
authors.lastname: Marinaki
authors.forename: M
authors.initials: M
authors.lastname: Arenas
authors.forename: T H J
authors.initials: TH
authors.lastname: Florin
mesh_terms: D001379:Azathioprine / Q000009:adverse effects*; D020022:Genetic Predisposition to Disease; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy* / Q000235:genetics; D008780:Methyltransferases / Q000235:genetics*; D011755:Pyrophosphatases / Q000235:genetics*; D000097630:Inosine Triphosphatase
chemical_list: D001379:Azathioprine; D007166:Immunosuppressive Agents; D008780:Methyltransferases; D011755:Pyrophosphatases; C022745:thiopurine methyltransferase; C511829:ITPA protein, human; D000097630:Inosine Triphosphatase